133 related articles for article (PubMed ID: 31167647)
1. Entropy of mitochondrial DNA circulating in blood is associated with hepatocellular carcinoma.
Campo DS; Nayak V; Srinivasamoorthy G; Khudyakov Y
BMC Med Genomics; 2019 Jun; 12(Suppl 4):74. PubMed ID: 31167647
[TBL] [Abstract][Full Text] [Related]
2. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients.
Okochi O; Hibi K; Uemura T; Inoue S; Takeda S; Kaneko T; Nakao A
Clin Cancer Res; 2002 Sep; 8(9):2875-8. PubMed ID: 12231530
[TBL] [Abstract][Full Text] [Related]
3. Multi-regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer.
Li X; Guo X; Li D; Du X; Yin C; Chen C; Fang W; Bian Z; Zhang J; Li B; Yang H; Xing J
Int J Cancer; 2018 Sep; 143(5):1143-1152. PubMed ID: 29569724
[TBL] [Abstract][Full Text] [Related]
4. Evidence of Neutral Evolution of Mitochondrial DNA in Human Hepatocellular Carcinoma.
Liu Q; Lin D; Li M; Gu Z; Zhao Y
Genome Biol Evol; 2019 Oct; 11(10):2909-2916. PubMed ID: 31599941
[TBL] [Abstract][Full Text] [Related]
5. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
Tamori A; Nishiguchi S; Nishikawa M; Kubo S; Koh N; Hirohashi K; Shiomi S; Inoue M
J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
[TBL] [Abstract][Full Text] [Related]
6. Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma.
Tao K; Bian Z; Zhang Q; Guo X; Yin C; Wang Y; Zhou K; Wan S; Shi M; Bao D; Yang C; Xing J
EBioMedicine; 2020 Jun; 56():102811. PubMed ID: 32512514
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma.
Nomoto S; Yamashita K; Koshikawa K; Nakao A; Sidransky D
Clin Cancer Res; 2002 Feb; 8(2):481-7. PubMed ID: 11839667
[TBL] [Abstract][Full Text] [Related]
8. Association of mitochondrial DNA content in peripheral blood leukocyte with hepatitis B virus-related hepatocellular carcinoma in a Chinese Han population.
Zhao S; Yang Y; Liu J; Liu H; Ge N; Yang H; Zhang H; Xing J
Cancer Sci; 2011 Aug; 102(8):1553-8. PubMed ID: 21521418
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma.
Hsu CC; Lee HC; Wei YH
World J Gastroenterol; 2013 Dec; 19(47):8880-6. PubMed ID: 24379611
[TBL] [Abstract][Full Text] [Related]
10. Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma.
Yin PH; Lee HC; Chau GY; Wu YT; Li SH; Lui WY; Wei YH; Liu TY; Chi CW
Br J Cancer; 2004 Jun; 90(12):2390-6. PubMed ID: 15150555
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study.
Wu MY; Kuo CS; Lin CY; Lu CL; Syu Huang RF
Br J Nutr; 2009 Sep; 102(5):715-21. PubMed ID: 19331700
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial apurinic/apyrimidinic endonuclease 1 enhances mtDNA repair contributing to cell proliferation and mitochondrial integrity in early stages of hepatocellular carcinoma.
Bazzani V; Barchiesi A; Radecka D; Pravisani R; Guadagno A; Di Loreto C; Baccarani U; Vascotto C
BMC Cancer; 2020 Oct; 20(1):969. PubMed ID: 33028238
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
Kelley RK; Magbanua MJ; Butler TM; Collisson EA; Hwang J; Sidiropoulos N; Evason K; McWhirter RM; Hameed B; Wayne EM; Yao FY; Venook AP; Park JW
BMC Cancer; 2015 Mar; 15():206. PubMed ID: 25884197
[TBL] [Abstract][Full Text] [Related]
14. Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection.
Li L; Hann HW; Wan S; Hann RS; Wang C; Lai Y; Ye X; Evans A; Myers RE; Ye Z; Li B; Xing J; Yang H
Sci Rep; 2016 Apr; 6():23992. PubMed ID: 27063412
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma.
Cai ZX; Chen G; Zeng YY; Dong XQ; Lin MJ; Huang XH; Zhang D; Liu XL; Liu JF
Int J Cancer; 2017 Sep; 141(5):977-985. PubMed ID: 28543104
[TBL] [Abstract][Full Text] [Related]
16. [Changes of the mitochondrial DNA copy number and the antioxidant system in the PBMC of hepatocellular carcinoma].
Gao Y; Nie HJ; Yang D; Ding CS; Jin M; Chen ZQ; Qiu ZG; Guo X; Chen ZL; Li JW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Jan; 32(1):1-5. PubMed ID: 27255030
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma.
Lee HC; Li SH; Lin JC; Wu CC; Yeh DC; Wei YH
Mutat Res; 2004 Mar; 547(1-2):71-8. PubMed ID: 15013701
[TBL] [Abstract][Full Text] [Related]
18. Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma.
Yamada S; Nomoto S; Fujii T; Kaneko T; Takeda S; Inoue S; Kanazumi N; Nakao A
Eur J Surg Oncol; 2006 Apr; 32(3):303-7. PubMed ID: 16478656
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma.
Nishikawa M; Nishiguchi S; Shiomi S; Tamori A; Koh N; Takeda T; Kubo S; Hirohashi K; Kinoshita H; Sato E; Inoue M
Cancer Res; 2001 Mar; 61(5):1843-5. PubMed ID: 11280735
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in POLG were associated with the prognosis and mtDNA content in hepatocellular carcinoma patients.
Long X; Wang X; Chen Y; Guo X; Zhou F; Fan Y; Ge N; Guo M; Zhang Z; Dong G
Bull Cancer; 2017 Jun; 104(6):500-507. PubMed ID: 28457473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]